DEF 14A

Company

Summit Therapeutics Inc.

Filed

July 6, 2022

Period of Report

July 6, 2022

Accession Number

0001599298-22-000069

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →